ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 59

Downregulated Forkhead-Box Class O Transcription Factors Attenuate Oxidative Stress Resistance In Human Chondrocytes

Yukio Akasaki and Martin K. Lotz, Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Aging, cartilage, chondrocytes and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint (Cartilage and Osteoarthritis)

Session Type: Abstract Submissions (ACR)

Background/Purpose: Aging-associated changes in articular chondrocytes represent a major risk factor for osteoarthritis (OA). The major signaling pathway that regulates cellular aging is the Insulin/IGF-1/Pl3k/Akt/forkhead-box class O (FoxO) transcription factor axis. The FoxO factors play a central role in oxidative stress resistance regulating antioxidants, autophagy and protein quality control. Previously, we observed that FoxO factors are dysregulated in aged and OA cartilage. FoxO expression is reduced during the aging process and phosphorylation of FoxOs (inactivation form) is increased in OA cartilage. However, the impact of downregulated FoxOs on chondrocytes is still unknown. The objective of this study was to investigate the role of FoxOs in anti-oxidative stress resistance in human chondrocytes.

Methods: Normal human cartilage was obtained at autopsy from 4 adult donors. OA human cartilage was obtained from 5 patients undergoing knee replacement surgery. Small interference RNA for FoxO1 and FoxO3 were transfected into chondrocytes. The effects of down-regulated FoxO proteins on cell viability against the oxidant tert-Butyl hydroperoxide (t-BHP) were analyzed by MTT assay. Antioxidants and autophagy related proteins in FoxO-siRNA transfected cells were analyzed by Western blot. The changes in inflammatory mediators and extracellular matrix components following treatment with IL-1β or TGF-β were also examined.

Results: FoxO1 and FoxO3 but not FoxO4 mRNA expression was significantly lower in OA cartilage compared to normal cartilage. MTT assay showed that the combination of siFoxO1 and siFoxO3 significantly reduced cell viability compared to control siRNA under treatment with t-BHP (≥ 50 μM) (Figure 1). Knock-down of FoxO1 and FoxO1+3 resulted in significant reductions of GPX-1, catalase, LC3, Beclin1, p62, and Sirt1 proteins following treatment with t-BHP. Expression of iNOS was significantly increased in FoxO-siRNA transfected chondrocytes.

Conclusion: Down-regulated FoxO transcription factors in chondrocytes increased susceptibility to cell death induced by oxidative stress, and this was associated with reduced antioxidants and autophagy related proteins. Our data provide evidence for a key role of FoxO transcription factors as regulators of oxidative stress resistance in human chondrocytes.


Disclosure:

Y. Akasaki,
None;

M. K. Lotz,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/downregulated-forkhead-box-class-o-transcription-factors-attenuate-oxidative-stress-resistance-in-human-chondrocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology